Open source drug discovery gets its day in the sun

10/24/2013 | Xconomy

Merck, Johnson & Johnson and Sanofi recently launched open source drug development projects that "represent a sea change in the pre-competitive landscape for pharmaceutical development," writes John Wilbanks, a senior fellow at FasterCures and chief commons officer at Sage Bionetworks. The open source movement in drug discovery is being driven by massive public investment in health and biology, as well as governmental and institutional momentum to open knowledge bases for reuse and recombination, Wilbanks writes. "This level of progress would have been unthinkable just a decade ago at the height of the first genomics bubble," he writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ